Study at a glance
What was the question?
Does vitamin D affect the beginning of an immune attack against the body? This review separates early antibody detection, immune-cell function and later diabetes. These measurements answer different questions.
Who or what was studied?
Two studies followed children at increased genetic risk of type 1 diabetes. Three investigations used mice prone to autoimmune diabetes. The mouse studies tested dietary vitamin D3, loss of its receptor or treatment with the active hormone.
What did the studies find?
One childhood study linked higher vitamin D status with fewer early autoimmune markers. The other did not find a clear association. Mouse experiments changed diabetes outcomes under particular conditions. One tested whether transferred cells could suppress disease. Another showed why organ function can affect when diabetes becomes apparent.
What does this mean?
These studies do not establish that supplements prevent human autoimmunity. Mouse findings do not supply a personal dose or target blood level. Changes in cell markers or gut microbes do not prove they caused protection. Showing that cells restrain an immune attack is different from detecting antibodies or diagnosing disease.
Read the full article below ↓The beginning of autoimmunity is difficult to study. Researchers can detect antibodies against the body’s tissues, test what immune cells do, or record a later diagnosis. These are related but different observations. Five vitamin D investigations help distinguish early autoimmune markers from functional immune restraint and clinical diabetes. For the detailed analysis, read Vitamin D and Autoimmune Initiation: Full Evidence Review.
The childhood findings were mixed
TEDDY followed children at increased genetic risk of type 1 diabetes. Higher measured vitamin D status was associated with lower odds of persistent islet autoantibodies. These antibodies indicate an immune response directed at pancreatic islets. The study did not randomly assign supplements, so it could not establish that supplements prevented the response. Its childhood-average measurement included the first antibody-positive visit; it was not entirely before biological initiation. [1]
DAISY, another higher-risk childhood cohort, did not find a clear association between measured vitamin D status and islet autoimmunity or later progression to diabetes. This challenges a consistent protective interpretation. It does not prove there is exactly no effect. The cohorts used different measurement windows, analysis subsets and exposure increments, making a simple numerical comparison misleading. [2]
The distinction matters for Vitamin D and Adaptive Immunity: antibodies show a targeted response, while a clinical diagnosis also reflects the condition of the affected organ. Neither measurement alone reconstructs every step by which tolerance was lost.
Mouse studies asked more direct experimental questions
Martens and colleagues changed dietary vitamin D3 in female mice prone to autoimmune diabetes. The higher dietary arm had less diabetes, while the lower supplemented arm did not show the same protection. Calcium and phosphate were raised in the higher arm. The result is not a human dose recommendation or safety assurance. Immune and microbial changes did not establish which mechanism caused protection, and increased gut permeability was not corrected. [3]
Driver and colleagues removed the vitamin D receptor throughout the animal. Their experiments showed why metabolic and insulin-secretory conditions can affect when diabetes becomes apparent, without simply meaning stronger immune aggression. Receptor deletion is not ordinary low vitamin D status. The rescue diet changed several ingredients, not just calcium. Four supplementary figures were unavailable, so detailed claims about preserved regulatory-cell function are not included. [4]
Casteels and colleagues tested active calcitriol in a drug-perturbed mouse model. Cell transfers and co-transfers supplied functional evidence about disease-producing activity and suppression. These tests went beyond counting cells with regulatory markers. They did not identify a purified modern regulatory-T-cell population or prove restoration of human self-tolerance. The missing Figure 4 caption also limits detailed apoptosis claims. [5]
Function and prevention remain different claims
Vitamin D and Immune Tolerance concerns restraint of harmful self-directed responses. In this evidence set, the most direct functional tests came from manipulated mice. The human studies were more relevant to childhood disease development, but their associations differed. The mouse investigations also shared research networks and model lineage, so they are not three unrelated replications.
Vitamin D, T-Cell Differentiation and Regulatory Balance: Full Evidence Review explains why a marker change is not enough to prove function. Here, functional suppression, early antibody detection and clinical diabetes must each retain their meaning. The selected studies do not establish a complete human pathway from vitamin D intake to preserved tolerance and prevented disease. They support further biological investigation, not a personal prevention regimen.
Scientific sources and access
Evidence assessed on 5 November 2026. This is an original synthesis of selected research, not a reproduction of the papers or a systematic review. Material source-access limits are identified in the analysis.
[1] Norris and colleagues. Plasma 25-Hydroxyvitamin D Concentration and Risk of Islet Autoimmunity. Diabetes. 2018 Jan;67(1):146 to 154. DOI: 10.2337/db17-0802. PMID: 29061729.
[2] Simpson and colleagues. No association of vitamin D intake or 25-hydroxyvitamin D levels in childhood with risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY). Diabetologia. 2011 Nov;54(11):2779 to 2788. DOI: 10.1007/s00125-011-2278-2. PMID: 21858504.
[3] Martens and colleagues. High Serum Vitamin D Concentrations, Induced via Diet, Trigger Immune and Intestinal Microbiota Alterations Leading to Type 1 Diabetes Protection in NOD Mice. Frontiers in immunology. 2022;13:902678. DOI: 10.3389/fimmu.2022.902678. PMID: 35784365.
[4] Driver and colleagues. Calcium insufficiency accelerates type 1 diabetes in vitamin D receptor-deficient nonobese diabetic (NOD) mice. Endocrinology. 2011 Dec;152(12):4620 to 4629. DOI: 10.1210/en.2011-1074. PMID: 21952242.
[5] Casteels and colleagues. 1,25-Dihydroxyvitamin D3 restores sensitivity to cyclophosphamide-induced apoptosis in non-obese diabetic (NOD) mice and protects against diabetes. Clinical and experimental immunology. 1998 May;112(2):181 to 187. DOI: 10.1046/j.1365-2249.1998.00568.x. PMID: 9649179.
Related reading
Combination therapy with saxagliptin and vitamin D for the preservation of β-cell function in adult-onset type 1 diabetes: a multi-center, randomized, controlled trial
Here, we conducted a multi-centre, randomized, controlled trial to assess the β-cell preservation effects of saxagliptin alone and saxagliptin combined with vitamin D as adjunctive therapies in adult-onset autoimmune type 1 diabetes.
Original paper ↗Read more →Vitamin D and Autoimmune Initiation: Full Evidence Review
Compare childhood autoantibody findings with mouse experiments on immune suppression and diabetes, with conflicting results and clear limits.
Read more →High frequency of vitamin D receptor gene polymorphism FokI in Brazilian Type 1 diabetes mellitus patients with clinical autoimmune thyroid disease
The aim of this study was to evaluate the relationship between VDR FokI polymorphism (rs10735810), thyroid autoimmunity and thyroid dysfunction (TD) in Brazilian T1DM.
Original paper ↗Read more →Type 1 Diabetes and Other Autoimmune Diseases: Epidemiology, Pathophysiology and Screening
A comprehensive review of literature on T1D and associated AID was conducted, with the aim of drawing informed conclusions relevant to clinical practice.
Original paper ↗Read more →Autoimmune Phenotype Confirmation Intervals and Clinical Indicators in Patients With Latent Autoimmune Diabetes in Adults (LADA) in Southwest China: A Multicenter Retrospective Cross‐Sectional Study
This study is aimed at quantifying the duration of this interval and identifying clinical indicators of prolonged confirmation intervals among hospitalized patients in this understudied region.
Original paper ↗Read more →Fat Mass Influences Femur Bone Strength and Geometry Parameters, but Not Bone Mineral Density, in Autoimmune Diabetes: A Pilot Study
This study examines how adiposity influences BMD and Dual X‐Ray Absorptiometry (DXA)‐derived parameters of bone geometry and strength in AD.
Original paper ↗Read more →How Does Vitamin D Affect Immune Cells Crosstalk in Autoimmune Diseases?
Vitamin D is a secosteroid hormone that is highly involved in bone health.
Original paper ↗Read more →Vitamin D Supplementation as a Therapeutic Strategy in Autoimmune Diabetes: Insights and Implications for LADA Management
By distilling and consolidating existing research, we aim to provide a platform for advancing targeted investigations within this distinct patient population.
Original paper ↗Read more →Altered Expression of Vitamin D Metabolism Genes and Circulating MicroRNAs in PBMCs of Patients with Type 1 Diabetes: Their Association with Vitamin D Status and Ongoing Islet Autoimmunity
This study aimed to decipher differences in the expression of genes associated with vitamin D metabolism in T1DM patients and to ascertain if there is a correlation between serum 1,25(OH)2D3 levels and the expression of these genes.
Original paper ↗Read more →Type 1 Diabetes Autoimmunity: To What Extent Vitamin D is Beneficial
Moreover, the coupled therapy and clinical trials that have investigated the use of vitamin D as a therapeutic intervention for autoimmune disorders were also examined, highlighting both successes and limitations.
Original paper ↗Read more →Combined Use of Vitamin D and DPP-4 Inhibitors as a Potential Adjuvant Treatment Strategy to Enhance the Efficacy of Novel Beta-Cell Replacement Therapies for Type 1 Diabetes
Emerging evidence suggests that vitamin D and dipeptidyl peptidase-4 (DPP-4) inhibitors exert synergistic immunomodulatory, anti-inflammatory and antioxidant actions.
Original paper ↗Read more →Effect of Calcitriol on Bone Turnover and Osteocalcin in Recent-Onset Type 1 Diabetes
We investigated the effect of supplementation with calcitriol on bone turnover in recent-onset type 1 diabetes (T1D).
Original paper ↗Read more →Immunomodulatory Effect of Vitamin D and Its Potential Role in the Prevention and Treatment of Type 1 Diabetes Mellitus: A Narrative Review
The aim of this narrative review is to present the molecular mechanisms for the vitamin D immunomodulatory effect as well as review human clinical studies on the use of vitamin D as adjuvant therapy in type 1 diabetes mellitus.
Original paper ↗Read more →Leptin and IGF-1 in Infancy Are Associated With Variants in DHCR7 and CYP2R1 That Relate With Type 1 Diabetes and 25OHD
Vitamin D has been variably implicated in risk of developing type 1 diabetes based on cohorts of at-risk individuals.
Original paper ↗Read more →Prevalence and characteristics of overweight/obesity in children newly diagnosed with type 1 diabetes in Kuwait
Overweight/obese children were older at diagnosis compared to non-obese children (median age 9.3 vs.
Original paper ↗Read more →25-hydroxyvitamin D and the initial presentation of pediatric type 1 diabetes: associations with ketoacidosis severity and beta-cell function
This study included 99 children with new-onset Type 1 Diabetes Mellitus (T1DM).
Original paper ↗Read more →VDR FokI Polymorphism and Immune-Cell Function: Full Evidence Review
In-depth evidence review of a verified primary study examining common vitamin D receptor (VDR) polymorphisms, their functional characteristics, and implications for vitamin D signalling and biological response variability.
Read more →Comparative Analysis of Gut Microbiota Patterns in Irritable Bowel Syndrome, Anxiety, and Autoimmune Disorders
Lactate production was significantly lower in both the AI (p = 0.014) and AG (p = 0.038) compared to HC.
Original paper ↗Read more →Meta-Analysis of the Association between Vitamin D and Autoimmune Thyroid Disease
The aim was to evaluate the association between vitamin D levels and AITD through systematic literature review.
Original paper ↗Read more →The Role of Vitamin D in Autoimmune Diseases
Vitamin D is a steroid hormone whose relevant immunomodulatory role has been widely described.
Original paper ↗Read more →Vitamin D3 Metabolism and Its Role in Temporomandibular Joint Osteoarthritis and Autoimmune Thyroid Diseases
The aim of this review was to present the metabolism of vitamin D3, as well as to discuss the role of vitamin D3 in bone metabolism, temporomandibular joint osteoarthritis (TMJ OA), and autoimmune thyroid diseases (AITD) on the basis of the literature.
Original paper ↗Read more →Original sources
Plasma 25-Hydroxyvitamin D Concentration and Risk of Islet Autoimmunity
[1] Norris and colleagues.
Publication details
[1] Norris and colleagues. Plasma 25-Hydroxyvitamin D Concentration and Risk of Islet Autoimmunity. Diabetes. 2018 Jan;67(1):146 to 154. DOI: 10.2337/db17-0802. PMID: 29061729.
No association of vitamin D intake or 25-hydroxyvitamin D levels in childhood with risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY)
[2] Simpson and colleagues.
Publication details
[2] Simpson and colleagues. No association of vitamin D intake or 25-hydroxyvitamin D levels in childhood with risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY). Diabetologia. 2011 Nov;54(11):2779 to 2788. DOI: 10.1007/s00125-011-2278-2. PMID: 21858504.
High Serum Vitamin D Concentrations, Induced via Diet, Trigger Immune and Intestinal Microbiota Alterations Leading to Type 1 Diabetes Protection in NOD Mice
Published in Frontiers in immunology (2022).
Publication details
[3] Martens and colleagues. High Serum Vitamin D Concentrations, Induced via Diet, Trigger Immune and Intestinal Microbiota Alterations Leading to Type 1 Diabetes Protection in NOD Mice. Frontiers in immunology. 2022;13:902678. DOI: 10.3389/fimmu.2022.902678. PMID: 35784365.
Calcium insufficiency accelerates type 1 diabetes in vitamin D receptor-deficient nonobese diabetic (NOD) mice
[4] Driver and colleagues.
Publication details
[4] Driver and colleagues. Calcium insufficiency accelerates type 1 diabetes in vitamin D receptor-deficient nonobese diabetic (NOD) mice. Endocrinology. 2011 Dec;152(12):4620 to 4629. DOI: 10.1210/en.2011-1074. PMID: 21952242.
1,25-Dihydroxyvitamin D3 restores sensitivity to cyclophosphamide-induced apoptosis in non-obese diabetic (NOD) mice and protects against diabetes
Published in Clinical and experimental immunology. 1998 May;112(2):181 to 187. DOI: 10.1046/j.1365-2249 (1998).
Publication details
[5] Casteels and colleagues. 1,25-Dihydroxyvitamin D3 restores sensitivity to cyclophosphamide-induced apoptosis in non-obese diabetic (NOD) mice and protects against diabetes. Clinical and experimental immunology. 1998 May;112(2):181 to 187. DOI: 10.1046/j.1365-2249.1998.00568.x. PMID: 9649179.